Daiwa Securities Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.2M | Sell |
67,539
-3,056
| -4% | -$1.42M | 0.09% | 129 |
|
|
2025
Q4 | $32M | Buy |
70,595
+3,368
| +5% | +$1.45M | 0.1% | 132 |
|
|
2025
Q3 | $26.3M | Sell |
67,227
-8,605
| -11% | -$3.6M | 0.09% | 142 |
|
|
2025
Q2 | $33.8M | Buy |
75,832
+4,600
| +6% | +$2.12M | 0.12% | 109 |
|
|
2025
Q1 | $34.5M | Buy |
71,232
+5,504
| +8% | +$2.56M | 0.15% | 100 |
|
|
2024
Q4 | $26.5M | Buy |
65,728
+7,861
| +14% | +$3.64M | 0.12% | 108 |
|
|
2024
Q3 | $26.9M | Buy |
57,867
+14,194
| +33% | +$6.82M | 0.12% | 104 |
|
|
2024
Q2 | $20.5M | Sell |
43,673
-255
| -0.6% | -$111K | 0.11% | 118 |
|
|
2024
Q1 | $18.4M | Buy |
43,928
+6,941
| +19% | +$2.93M | 0.1% | 119 |
|
|
2023
Q4 | $15M | Buy |
36,987
+351
| +1% | +$130K | 0.09% | 123 |
|
|
2023
Q3 | $12.7M | Buy |
36,636
+5,572
| +18% | +$1.95M | 0.09% | 135 |
|
|
2023
Q2 | $10.9M | Buy |
31,064
+106
| +0.3% | +$35.7K | 0.07% | 151 |
|
|
2023
Q1 | $9.75M | Buy |
30,958
+1,296
| +4% | +$389K | 0.07% | 160 |
|
|
2022
Q4 | $8.57M | Buy |
29,662
+388
| +1% | +$118K | 0.07% | 180 |
|
|
2022
Q3 | $8.48M | Buy |
29,274
+1,145
| +4% | +$329K | 0.07% | 161 |
|
|
2022
Q2 | $7.93M | Buy |
28,129
+1,582
| +6% | +$423K | 0.06% | 176 |
|
|
2022
Q1 | $6.93M | Buy |
26,547
+3,372
| +15% | +$800K | 0.04% | 220 |
|
|
2021
Q4 | $5.09M | Buy |
23,175
+1,483
| +7% | +$288K | 0.03% | 286 |
|
|
2021
Q3 | $3.94M | Buy |
21,692
+1,899
| +10% | +$371K | 0.03% | 314 |
|
|
2021
Q2 | $3.99M | Buy |
19,793
+932
| +5% | +$195K | 0.03% | 294 |
|
|
2021
Q1 | $4.05M | Buy |
18,861
+1,698
| +10% | +$373K | 0.03% | 257 |
|
|
2020
Q4 | $4.06M | Sell |
17,163
-28,290
| -62% | -$6.49M | 0.03% | 241 |
|
|
2020
Q3 | $12.4M | Buy |
45,453
+14,382
| +46% | +$3.97M | 0.11% | 88 |
|
|
2020
Q2 | $7.39M | Hold |
31,071
| – | – | 0.16% | 81 |
|
|
2020
Q1 | $7.39M | Buy |
31,071
+18,639
| +150% | +$4.28M | 0.08% | 131 |
|
|
2019
Q4 | $2.72M | Buy |
12,432
+4
| +0% | +$810 | 0.02% | 289 |
|
|
2019
Q3 | $2.11M | Buy |
12,428
+622
| +5% | +$110K | 0.02% | 337 |
|
|
2019
Q2 | $2.17M | Buy |
11,806
+61
| +0.5% | +$10.7K | 0.02% | 318 |
|
|
2019
Q1 | $2.16M | Buy |
11,745
+858
| +8% | +$158K | 0.02% | 321 |
|
|
2018
Q4 | $1.8M | Buy |
10,887
+540
| +5% | +$93.6K | 0.02% | 335 |
|
|
2018
Q3 | $1.99M | Buy |
10,347
+533
| +5% | +$94.9K | 0.02% | 372 |
|
|
2018
Q2 | $1.67M | Sell |
9,814
-301
| -3% | -$46.7K | 0.01% | 404 |
|
|
2018
Q1 | $1.65M | Buy |
10,115
+2,553
| +34% | +$417K | 0.01% | 406 |
|
|
2017
Q4 | $1.13M | Buy |
7,562
+1
| +0% | +$148 | 0.01% | 476 |
|
|
2017
Q3 | $1.15M | Buy |
7,561
+391
| +5% | +$58.9K | 0.01% | 435 |
|
|
2017
Q2 | $924K | Buy |
7,170
+220
| +3% | +$26.5K | 0.01% | 465 |
|
|
2017
Q1 | $760K | Buy |
6,950
+650
| +10% | +$57.2K | ﹤0.01% | 502 |
|
|
2016
Q4 | $464K | Buy |
6,300
+250
| +4% | +$20.3K | ﹤0.01% | 563 |
|
|
2016
Q3 | $528K | Buy |
6,050
+250
| +4% | +$23.6K | ﹤0.01% | 498 |
|
|
2016
Q2 | $499K | Hold |
5,800
| – | – | ﹤0.01% | 495 |
|
|
2016
Q1 | $461K | Sell |
5,800
-32,400
| -85% | -$2.93M | ﹤0.01% | 499 |
|
|
2015
Q4 | $4.81M | Buy |
38,200
+32,600
| +582% | +$3.94M | 0.03% | 170 |
|
|
2015
Q3 | $583K | Hold |
5,600
| – | – | ﹤0.01% | 455 |
|
|
2015
Q2 | $691K | Hold |
5,600
| – | – | ﹤0.01% | 457 |
|
|
2015
Q1 | $661K | Sell |
5,600
-20,470
| -79% | -$2.45M | ﹤0.01% | 408 |
|
|
2014
Q4 | $3.1M | Buy |
26,070
+17,430
| +202% | +$1.96M | 0.02% | 217 |
|
|
2014
Q3 | $970K | Buy |
8,640
+2,140
| +33% | +$204K | 0.01% | 295 |
|
|
2014
Q2 | $615K | Hold |
6,500
| – | – | ﹤0.01% | 364 |
|
|
2014
Q1 | $460K | Hold |
6,500
| – | – | ﹤0.01% | 410 |
|
|
2013
Q4 | $483K | Hold |
6,500
| – | – | ﹤0.01% | 387 |
|
|
2013
Q3 | $493K | Hold |
6,500
| – | – | ﹤0.01% | 385 |
|
|
2013
Q2 | $520K | Buy |
+6,500
| New | +$479K | ﹤0.01% | 402 |
|
Other funds holding VRTX
VCM
VPM
Daiwa Securities Group's VRTX Position: Q1 2026 in Review
Daiwa Securities Group reduced its Vertex Pharmaceuticals (VRTX) stake by 4.3% in Q1 2026, selling an estimated $1.42M and leaving 67,539 shares worth $30.2M. The position accounts for 0.09% of the portfolio, ranked #129.
Daiwa Securities Group first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.5M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Daiwa Securities Group held 67,539 shares of Vertex Pharmaceuticals worth $30.2M as of Q1 2026.
- Daiwa Securities Group sold 3,056 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.42M.
- Vertex Pharmaceuticals made up 0.09% of Daiwa Securities Group's portfolio in Q1 2026, its #129 holding.
- Daiwa Securities Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Daiwa Securities Group's Vertex Pharmaceuticals position peaked at $34.5M in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.